100mg per vial; reconstitute to 20mL (5mg/mL suspension)
Dosage Form
Sterile Lyophilized Powder for Suspension for Intravenous Infusion
Active Ingredient
Paclitaxel (bound to albumin nanoparticles)
Formulation Technology
Nab-technology (albumin-bound nanoparticle formulation; approximately 130nm particle size)
Pharmacological Class
Taxane-Class Antineoplastic Agent
Route of Administration
Intravenous infusion only (after reconstitution and dilution)
Packaging
100mg lyophilized powder in glass vial with rubber stopper and aluminum flip-off cap
Storage
Store at 20°C to 25°C (excursions permitted between 15°C and 30°C). Do not refrigerate or freeze. Protect from light. Keep vial in outer carton until use.
Shelf Life
36 months (unopened, dry powder)
Product Overview
Paclitaxel for Injection (Albumin Bound) 100mg is a sterile, lyophilized formulation of paclitaxel in which the active drug is bound to albumin nanoparticles using nab-technology (nanoparticle albumin-bound technology). Each vial contains 100mg of paclitaxel as a white to yellow, sterile lyophilized powder. After reconstitution with 20mL of 0.9% Sodium Chloride Injection, the resulting suspension has a concentration of 5mg/mL and appears as a uniform, milky-white suspension of albumin-bound paclitaxel nanoparticles with an average particle size of approximately 130 nanometers.
